Symposium on the role of SGLT2i in tackling cardiorenal risk in diabetes
This accredited symposium " Teaming up to tackle cardiorenal risk in diabetes - Role of SGLT2i: How to overcome clinical inertia" was held during the virtual EASD 2021.
Melanie Davies, MD, is Professor of Diabetes Medicine at the University of Leicester, UK.
Prof. Nikolaus Marx, Professor of Medicine / Cardiology, Head of Department of Internal Medicine I, Cardiology, Angiology, and Intensive Care Medicine, University Hospital Aachen, Germany.
This recording was independently developed under auspices of PACE-cme. The views expressed in this recording are those of the individual presenter and do not necessarily reflect the views of PACE-cme.
Funding for this educational program was provided by an unrestricted educational grant received from Boehringer Ingelheim / Lilly.
Share this page with your colleagues and friends: